about
Sin3b interacts with Myc and decreases Myc levelsSmall molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivoThe putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progressionEpstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoproteinmrtl-A translation/localization regulatory protein encoded within the human c-myc locus and distributed throughout the endoplasmic and nucleoplasmic reticular networkAP4 encodes a c-MYC-inducible repressor of p21Noninvasive molecular imaging of c-Myc activation in living miceLinks between metabolism and cancerMolecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targetsRoles of Werner syndrome protein in protection of genome integrityA genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expressionN-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factorStrategically targeting MYC in cancerIntrinsic and Tumor Microenvironment-Induced Metabolism Adaptations of T Cells and Impact on Their Differentiation and FunctionRegulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancerMYC and the art of microRNA maintenanceThe genomic stability of induced pluripotent stem cellsCancer cell metabolism: implications for therapeutic targetsNon-canonical progesterone signaling in granulosa cell functionMitochondrial structure, function and dynamics are temporally controlled by c-MycExperimental gastric carcinogenesis in Cebus apella nonhuman primatesc-Myc accelerates S-phase and requires WRN to avoid replication stressAltering chemosensitivity by modulating translation elongationThe yeast Hot1 transcription factor is critical for activating a single target gene, STL1Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseasesCurrent Status of Long Non-Coding RNAs in Human Breast CancerEpithelial cancers in the post-genomic era: should we reconsider our lifestyle?A cellular genetics approach identifies gene-drug interactions and pinpoints drug toxicity pathway nodesChk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibitionNew aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cellsInhibition of c-Myc overcomes cytotoxic drug resistance in acute myeloid leukemia cells by promoting differentiationSALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial CancerThe Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA bindingInhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53Targeted repression of AXIN2 and MYC gene expression using designer TALEsDeep sequencing of MYC DNA-binding sites in Burkitt lymphomaThree new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21Activation of a metabolic gene regulatory network downstream of mTOR complex 1MYC on the path to cancerMyc and Fgf Are Required for Zebrafish Neuromast Hair Cell Regeneration.
P2860
Q24299671-59EE1F94-78A5-4C84-ACC0-7F086C0CD75AQ24305423-25E1C5F6-D7DC-42CE-A012-DB10FCE2DF11Q24307439-3FC35F01-0F09-40B5-A083-ADDAE49F04ECQ24311421-427F2974-AD5E-4BA5-8382-3C1620C1D78CQ24315822-767171E5-1F07-478C-8242-341E9CE2FA73Q24316196-46FD33B3-A86B-41B5-BDD9-C46962D2C274Q24613516-A358C11A-2DBE-41D0-86C1-21F8F8101845Q24626229-AEA0FA4D-8879-4AEF-8200-77CA895F6A6FQ24629083-E8217D0C-A3D7-4CE2-BECD-EE6E71F4F170Q24643050-C5ACB21F-F3BA-4212-B9FA-DE7D4F57845AQ24651021-4C71B8E9-6F00-46EF-99F6-B131C1A601C7Q24656221-9FDDAF1F-34E7-4B5B-A964-94FD3C4611C4Q26747745-EBE4E1AB-A8FA-4938-B2F2-B1932D5BAB50Q26749556-D3B13B9C-AC63-4CDC-B6A9-248C1290C40CQ26775423-BBA829B7-ED6D-4164-BA58-A64F02146FAEQ26825457-D30EAE1D-BA07-45C8-957B-1AC2A466EC1EQ26998764-89BBAFB8-FC8A-4F17-94A6-3A1F184F1A46Q27013632-4A467BCE-E9B3-44BB-AE1A-BFEBF4164262Q27022751-9F4391F4-2067-41D7-A5B9-4A9E12EADBD9Q27302245-B539D799-68D8-4DE9-B6FA-3C745AA8C85DQ27332441-747517DC-BD18-4266-A9A0-434E8F42653AQ27347951-E430A537-7A93-4286-A4EC-7DD162B66368Q27349402-039CAA09-2018-4DE0-BFD3-9806C582E82DQ27936363-585AE752-68CD-46B5-9B2F-DC3CBF0E8812Q28071309-EF775917-5C90-484C-B0B2-73EFBC4B840BQ28079880-FB8630B2-EDCD-4E49-889C-8F5BE7DBFB98Q28391921-DACB8367-E3B7-48E3-A3F1-E55B1B83969EQ28393267-B44EDC17-CB6E-4AAA-B8E3-0F68850859A7Q28396027-22CF449D-11E4-4D82-A027-CB2413B47D1AQ28534587-6845FDAA-8B20-4754-BEAB-DFA0F5FE991AQ28542016-F78E3719-9D1B-4ECB-AA74-0D88D638EF08Q28548494-5F6293AC-89FB-4D43-8A08-33C3DB1A370EQ28567657-BA7FE62F-D50D-4F29-B31C-880B0400032CQ28589774-E0206C12-989D-4C5A-B630-8ECF0C361B85Q28655517-94643597-70C6-4027-BEBB-FCCF010D2C63Q28742928-4174C241-3F42-482F-97B2-9041A43A54CEQ29248193-590FCEC6-BE91-4919-836F-1FA05C9F69FFQ29615179-B9006996-39A7-4038-B377-21273AD5E6EEQ29619979-56BD844C-AC2C-4B4B-8C8D-A8423AC9ABCDQ30357606-A4F888C7-6BF4-4311-95A1-8E7D8EA49C97
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The c-Myc target gene network.
@ast
The c-Myc target gene network.
@en
type
label
The c-Myc target gene network.
@ast
The c-Myc target gene network.
@en
prefLabel
The c-Myc target gene network.
@ast
The c-Myc target gene network.
@en
P2093
P1476
The c-Myc target gene network.
@en
P2093
Chi V Dang
Karen I Zeller
Kathryn A O'Donnell
Rebecca C Osthus
Tam Nguyen
P304
P356
10.1016/J.SEMCANCER.2006.07.014
P577
2006-07-25T00:00:00Z